Skip to main content
. 2016 Feb 11;7(12):13680–13687. doi: 10.18632/oncotarget.7322

Table 4. Summary of the patients showing disagreement between the RECIST 1.0 and RECIST 1.1.

Reference Tumor type Tumor response No. of patients Causes of disagreement
RECIST 1.0 RECIST 1.1
Sun et al. [18] NSCLC PR CR 2 LNs < 10 mm
SD PR 3 Equivocal LNs
SD PD 1 A definitely increased LN
Nishino et al. [19] NSCLC SD PD 2 New lesions on PET
PD SD 1 A single LN < 10 mm
Nishino et al. [20] NSCLC SD PR 1 Decreased number of target lesion
Ruan et al. [21] TC SD PR 1 Not described
Krajewski et al. [23] RCC PD SD 1 LN < 15 mm and up to 2 target lesion per
SD PD 1 organ
SD PR 4 Three LNs targets by the RECIST 1.0
Not described
HHS Vulnerability Disclosure